Our website uses cookies to provide you with the best viewing experience. By continuing to browse our site without changing your settings, you are agreeing to accept all cookies on the site. You can change your internet browser settings yourself at anytime. Please refer to your browser's help menu. Keep in mind that our website may not function properly if you disable certain cookies.
MPS is moving into the mainstream. Is your lab ready?
Stop by our booth Sept. 25-27 to see our innovative neural bridging technology in action.
We're leading the way in development of new solutions for emerging environmental problems—like per- and polyfluoroalkyl substances (PFAS).
We're serving industry and government to ensure vaccine and therapeutic safety and efficacy.
We're protecting patients and their medical devices with our DeviceSecure Services to safeguard against cyber attacks.
Whether you’re trying to get a new vaccine or therapeutic to market or quantify the exposure risks of an industrial or agricultural chemical, you can count on the Battelle for the answers you need.
Our transportation experts can help solve technology challenges, plan, design and engineer safe and innovative transportation advancements, and help you assess the safety of existing systems.
We help the public health community understand the range of tobacco, marijuana and opioid products available, how consumers use those substances and the risks associated with them.
Battelle applies more than 30 years of experience in safety pharmacology services. We work closely with pharmaceutical and biotechnology companies to design better drugs and to establish the safety of drugs under development.
Battelle DroneDefender® Counter-UAS Device is a directed-energy unmanned aircraft system countermeasure. It quickly disrupts the adversary's control of the drone, neutralizing it so that no remote action can occur.
Massively parallel sequencing (MPS), also known as next-generation sequencing (NGS), is a mainstream technology in many academic areas and has led to discoveries in medicine, biology and environmental science.
After an exhaustive 19-month research project, massively parallel sequencing is proven to generate robust, reliable, reproducible results.
Toxicology safety testing teams are under more pressure than ever. Here are three significant innovations helping tox teams achieve more success.
The end of August brings more than just a holiday weekend and reminders that fall is fast approaching. For Battelle, it meant a very busy week.